ABBOTT PARK, Ill., April 20 /PRNewswire-FirstCall/ -- On Friday, April 21, Abbott will conduct a special conference call with the investment community and the media to provide an overview of the Guidant vascular transaction. Both the U.S. Federal Trade Commission and the European Commission have approved the transaction, which is expected to close tomorrow. Richard A. Gonzalez, president and chief operating officer, and Thomas C. Freyman, executive vice president, Finance and chief financial officer, will participate on the call.
A live webcast of the conference call will begin at 8 a.m. Central time (9 a.m. Eastern), and will be accessible through Abbott's Investor Relations Web site at http://www.abbottinvestor.com . An archived edition of the call will be available after 11 a.m., Central time.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 60,000 people and markets its products in more than 130 countries.
Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com .
AbbottCONTACT: Media, Jonathon Hamilton, +1-847-935-8646, or FinancialCommunity, Larry Peepo, +1-847-935-6722, both of Abbott
Company News On-Call: http://www.prnewswire.com/comp/121546.html /
